BR0214570A - Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno - Google Patents

Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno

Info

Publication number
BR0214570A
BR0214570A BR0214570-7A BR0214570A BR0214570A BR 0214570 A BR0214570 A BR 0214570A BR 0214570 A BR0214570 A BR 0214570A BR 0214570 A BR0214570 A BR 0214570A
Authority
BR
Brazil
Prior art keywords
abortion
prevention
endogenous
gestomene
immunomodulatory compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0214570-7A
Other languages
English (en)
Inventor
Jeannette Alt
Bernd Eisele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay Pharmaceuticals GmbH
Original Assignee
Solvay Pharmaceuticals GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharmaceuticals GmbH filed Critical Solvay Pharmaceuticals GmbH
Publication of BR0214570A publication Critical patent/BR0214570A/pt
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"PREVENçãO DO ABORTO COM COMPOSTOS IMUNOMODULANTES DE GESTAGENO NãO-ENDóGENO". A presente invenção refere-se à utilização de compostos de gestageno não-endógenos imunologicamente ativos, no tratamento e/ou profilaxia de aborto espontâneo ou habitual.
BR0214570-7A 2001-11-30 2002-11-26 Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno Withdrawn BR0214570A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33412401P 2001-11-30 2001-11-30
PCT/EP2002/013288 WO2003045361A1 (en) 2001-11-30 2002-11-26 Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds

Publications (1)

Publication Number Publication Date
BR0214570A true BR0214570A (pt) 2004-11-03

Family

ID=23305691

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0214570-7A Withdrawn BR0214570A (pt) 2001-11-30 2002-11-26 Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno

Country Status (8)

Country Link
US (1) US20050020553A1 (pt)
EP (1) EP1448178A1 (pt)
CN (1) CN1596107A (pt)
AU (1) AU2002365512A1 (pt)
BR (1) BR0214570A (pt)
PL (1) PL368744A1 (pt)
RU (1) RU2004120066A (pt)
WO (1) WO2003045361A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005078469A1 (en) * 2004-02-04 2005-08-25 E.I. Dupont De Nemours And Company The use of two or more sensors to detect different nuclear quadrupole resonance signals of a target compound
US8951996B2 (en) 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6954494A (en) * 1993-05-21 1994-12-20 Brigham And Women's Hospital Embryotoxic factors
DE4336343C2 (de) * 1993-10-25 1996-07-25 Mucos Pharma Gmbh & Co Verwendung von proteolytischen Enzymen zur Abortprophylaxe bei Schwangeren mit idiopathischem Abortus habitualis in der Anamnese

Also Published As

Publication number Publication date
RU2004120066A (ru) 2005-04-10
US20050020553A1 (en) 2005-01-27
CN1596107A (zh) 2005-03-16
WO2003045361A1 (en) 2003-06-05
EP1448178A1 (en) 2004-08-25
AU2002365512A1 (en) 2003-06-10
PL368744A1 (en) 2005-04-04

Similar Documents

Publication Publication Date Title
GB0025173D0 (en) Therapeutic agents
CA2384504A1 (en) Use of retigabin for treating neuropathic pain
BG108269A (en) Pyrazolopyrimidines as therapeutic agents
AU4086101A (en) Sulphonamido-substituted bridged bicycloalkyl derivatives
BR0210205A (pt) Antiinfecciosos
GB0005251D0 (en) Therapeutic compounds
WO2002067807A3 (en) Animal garment
BR0211769A (pt) Combinações antineoplásicas
ZA200300712B (en) Pharmaceutical compositions for the treatment of mucositis, stomatitis and Behcet's syndrome.
WO1999047131A3 (en) Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor
DE60010260D1 (de) Hydrierte blockcopolymerzusammensetzungen und verwendungen davon
AU2001279703A1 (en) Garment
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
MY121864A (en) Condensed thienopyrimidines with phosphodiesterase-v inhibiting action.
TR200402670T4 (tr) Obezitenin tedavisi ve/veya profilaksına uygun bileşiklerin bulunması için yöntem
MXPA03011123A (es) Almohadilla labial que tiene varios medios.
WO2001009122A3 (en) Serotonergic benzofurans
BR0214570A (pt) Prevenção do aborto com compostos imunomodulantes de gestageno não-endógeno
ES2175356T3 (es) Uso de (+)-alfa-(2,3-dimetoxifenil)-1-[2-(4 fluorofenil)et il[-4- piperidinmetanol en el tratamiento de trastornos depresivos y trastornos bipolares.
DK0813870T3 (da) Anvendelse af darifenacin til at forstærke kognitive funktioner
BR9810556A (pt) Beta-alcoxiacrilatos contra a malária
PL331882A1 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofurane amines and 2-amino cyclohepta[b]benzofuranes
BG104914A (en) Paroxetine maleate
BR0114065A (pt) Triazolo-epotilonas
FI19992274A (fi) Liitosyhde

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2064 DE 27/07/2010.